AGNG


Aging Population ETF

Fund Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

Fund Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Why AGNG?

High Growth Potential

AGNG enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

AGNG's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, AGNG delivers access to dozens of companies with high exposure to the Longevity theme.

Fund Details As of 09/15/21

Key Facts

Ticker AGNG
Inception Date 05/09/16
CUSIP 37954Y772
ISIN US37954Y7720
Bloomberg Index Ticker ILNGRNT
Primary Exchange Nasdaq
Number of Holdings 99

Stats & Fees

Net Assets $64,038,086
Net Asset Value (NAV) $30.21
Shares Outstanding 2,120,000
Total Expense Ratio 0.50%

Distributions

30-Day SEC Yield 0.60%
Distribution Frequency Semi-Annually

Fund Prices As of 09/15/21

NAV $30.21 Daily Change $0.04 0.12%
Market Price $30.11 Daily Change -$0.26 -0.86%
30-Day Median Bid-Ask Spread 0.29%

Performance History

As of recent
(06/30/21)
As of recent
(06/30/21)
Fund NAV Market Price Index
1 Year 25.20% 25.35% 25.55%
3 Years 14.63% 14.58% 14.88%
5 Years 15.28% 15.29% 15.61%
Since Inception 15.31% 15.81% 15.63%
1 Year 20.18% 20.59% 20.47%
3 Years 12.55% 12.54% 12.78%
5 Years 14.51% 14.53% 14.81%
Since Inception 15.09% 15.60% 15.39%
Year-to-Date 8.90% 9.47% 9.04%
1 Month 4.54% 4.71% 4.33%
3 Months 10.28% 10.14% 10.38%
Since Inception 108.02% 112.75% 111.10%
Year-to-Date 10.40% 11.08% 10.53%
1 Month 1.58% 1.54% 1.59%
3 Months 5.98% 6.25% 5.76%
Since Inception 110.88% 115.88% 114.00%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Fund Characteristics As of 09/15/21

Return on Equity 15.30%
Weighted Avg. Market Cap 89,200 M
2020 2021
Price-to-earnings 33.28 27.57
Price-to-book value 4.45 4.03

Source: AltaVista Research, LLC

Fund Risk Stats As of 09/15/21

Versus Beta
S&P 500 0.83
MSCI EAFE 0.80
MSCI Emg. Mkts 0.66
Standard Deviation 18.50%

Source: AltaVista Research, LLC

Sector Breakdown As of 08/31/21

% of Net Assets
Health Care 93.9
Real Estate 5.0
Information Technology 0.6
Industrials 0.3
Communication Services 0.3

Source: AltaVista Research, LLC

Country Breakdown As of 08/31/21

% of Net Assets
United States 57.2
Switzerland 8.8
Denmark 7.1
Japan 6.7
Britain 5.2
China 3.9
Ireland 3.3
South Korea 1.9
Belgium 1.5
Germany 1.3
France 0.7
Other/Cash 2.4

Source: AltaVista Research, LLC

Top Holdings As of 09/15/21

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
4.12 NOVOB DC NOVO NORDISK A/S-B BHC8X90 101.15 26,090 2,638,980.88
4.06 EW EDWARDS LIFESCIENCES CORP 2567116 121.02 21,457 2,596,726.14
3.85 REGN REGENERON PHARMACEUTICALS 2730190 652.00 3,780 2,464,560.00
3.59 LLY ELI LILLY & CO 2516152 233.73 9,846 2,301,305.58
3.43 RO SW ROCHE HOLDING AG-BR 7108918 425.83 5,153 2,194,292.77
3.28 BSX BOSTON SCIENTIFIC CORP 2113434 45.01 46,603 2,097,601.03
3.22 AZN ASTRAZENECA PLC-SPONS ADR 2989044 56.45 36,503 2,060,594.35
3.13 SYK STRYKER CORP 2853688 277.10 7,226 2,002,324.60
3.07 MDT MEDTRONIC PLC BTN1Y11 131.65 14,938 1,966,587.70
2.94 DXCM DEXCOM INC B0796X4 551.67 3,410 1,881,194.70
2.86 ABBV ABBVIE INC B92SR70 107.77 17,014 1,833,598.78
2.86 JNJ JOHNSON & JOHNSON 2475833 165.42 11,072 1,831,530.24
2.82 BMY BRISTOL-MYERS SQUIBB CO 2126335 62.00 29,149 1,807,238.00
2.69 4519 JP CHUGAI PHARMA CO 6196408 38.14 45,202 1,723,792.82
2.50 BIIB BIOGEN INC 2455965 299.21 5,357 1,602,867.97
2.48 AMGN AMGEN INC 2023607 218.13 7,286 1,589,295.18
2.40 ALC SW ALCON INC BJT1GR5 87.04 17,645 1,535,766.74
2.05 4543 JP TERUMO CORP 6885074 48.78 26,889 1,311,544.53
2.00 WELL WELLTOWER INC BYVYHH4 86.88 14,726 1,279,394.88
1.89 BGNE BEIGENE LTD-ADR BYYWPW6 375.33 3,227 1,211,189.91
1.77 068270 KS CELLTRION INC B0C5YV1 232.81 4,870 1,133,767.62
1.77 STMN SW STRAUMANN HOLDING AG-REG 7156832 2,005.11 564 1,130,883.97
1.75 4503 JP ASTELLAS PHARMA INC 6985383 17.02 65,803 1,119,846.10
1.68 ZBH ZIMMER BIOMET HO 2783815 146.01 7,383 1,077,991.83
1.54 GMAB DC GENMAB A/S 4595739 429.45 2,298 986,886.85
1.52 SGEN SEAGEN INC BLPK4D2 152.09 6,405 974,136.45
1.44 SOON SW SONOVA HOLDING AG-REG 7156036 405.48 2,275 922,474.57
1.17 VTR VENTAS INC 2927925 57.12 13,149 751,070.88
1.15 FME GR FRESENIUS MEDICA 5129074 71.03 10,393 738,233.42
1.13 UCB BB UCB SA 5596991 106.61 6,757 720,342.04
1.05 PODD INSULET CORP B1XGNW4 291.44 2,309 672,934.96
1.00 TFX TELEFLEX INC 2881407 388.67 1,644 638,973.48
0.96 EXAS EXACT SCIENCES CORP 2719951 104.65 5,900 617,435.00
0.88 ABMD ABIOMED INC 2003698 355.18 1,593 565,801.74
0.88 INCY INCYTE CORP 2471950 73.44 7,626 560,053.44
0.87 SN/ LN SMITH & NEPHEW PLC 0922320 18.27 30,621 559,386.28
0.83 3692 HK HANSOH PHARMACEU BJYKB72 2.55 208,000 529,806.91
0.73 DEMANT DC DEMANT A/S BZ01RF1 55.74 8,401 468,272.60
0.73 DVA DAVITA INC 2898087 121.93 3,840 468,211.20
0.71 NVCR NOVOCURE LTD BYSS4X4 126.83 3,576 453,544.08
0.62 COH AU COCHLEAR LTD 6211798 171.97 2,292 394,149.24
0.61 AMP IM AMPLIFON SPA B14NJ71 49.23 7,925 390,114.94
0.59 GN DC GN STORE NORD A/S 4501093 75.51 4,990 376,805.79
0.59 853 HK MICROPORT SCIENTIFIC CORP B676TW7 5.96 63,100 375,863.13
0.50 NBIX NEUROCRINE BIOSC 2623911 96.34 3,289 316,862.26
0.49 UTHR UNITED THERAPEUTICS CORP 2430412 204.27 1,520 310,490.40
0.43 ORP FP ORPEA 7339451 121.26 2,261 274,173.97
0.40 OHI OMEGA HEALTHCARE 2043274 32.20 8,013 258,018.60
0.35 EXEL EXELIXIS INC 2576941 20.47 10,832 221,731.04
0.34 DNLI DENALI THERAPEUTICS INC BD2B4V0 52.63 4,186 220,309.18
0.34 ALEC ALECTOR INC BJ4LDC4 24.26 8,986 218,000.36
0.33 MMSI MERIT MEDICAL SYSTEMS INC 2580555 72.39 2,943 213,043.77
0.33 BPMC BLUEPRINT MEDICINES CORP BWY52P3 103.73 2,029 210,468.17
0.32 HALO HALOZYME THERAPEUTICS INC 2975098 41.25 5,009 206,621.25
0.32 SILK SILK ROAD MEDICAL INC BGHVXJ7 57.09 3,551 202,726.59
0.31 ANGO ANGIODYNAMICS INC B00CR04 27.18 7,309 198,658.62
0.31 AED BB AEDIFICA B1G5XP1 134.26 1,472 197,635.27
0.31 4547 JP KISSEI PHARM CO 6494061 23.50 8,320 195,487.08
0.30 MNKD MANNKIND CORP BF081J4 4.67 40,969 191,325.23
0.30 LIVN LIVANOVA PLC BYMT0J1 84.97 2,238 190,162.86
0.30 AMED AMEDISYS INC 2024332 169.67 1,115 189,182.05
0.29 RYM NZ RYMAN HEALTHCARE LTD 6161525 10.79 17,278 186,503.99
0.29 LHCG LHC GROUP INC B06DT50 168.87 1,085 183,223.95
0.28 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.51 357,900 181,680.96
0.28 CSH-U CN CHARTWELL RETIRE B8S8C94 10.02 18,092 181,370.57
0.28 ITGR INTEGER HOLDINGS CORP BD06LM7 93.06 1,922 178,861.32
0.27 8086 JP NIPRO CORP 6641599 11.00 15,738 173,082.72
0.26 1858 HK BEIJING CHUNLI-H BVVPXP6 2.35 72,100 169,194.67
0.26 KORI FP KORIAN B1HKRM0 36.26 4,645 168,429.97
0.26 BKD BROOKDALE SR B0PZN33 6.55 25,349 166,035.95
0.26 INGN INOGEN INC BJSVLL5 48.73 3,365 163,976.45
0.25 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.53 306,947 161,732.72
0.25 NHC NATIONAL HEALTHCARE CORP 2139731 69.19 2,322 160,659.18
0.25 ARNA ARENA PHARMACEUTICALS INC BF3N4P3 59.09 2,676 158,124.84
0.25 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 1.23 128,200 157,176.29
0.25 EKTAB SS ELEKTA AB-B SHS B0M42T2 12.16 12,915 157,098.65
0.24 NUVA NUVASIVE INC B00GJC2 59.07 2,649 156,476.43
0.24 OMER OMEROS CORP B4NB858 15.55 9,995 155,422.25
0.24 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 46.11 3,341 154,053.51
0.24 AMRN AMARIN CORP PLC -ADR 2301938 5.16 29,441 151,915.56
0.23 SBRA SABRA HEALTH CAR B5NLBP6 15.65 9,570 149,770.50
0.23 ENSG ENSIGN GROUP INC/THE B1YWPP8 77.69 1,899 147,533.31
0.23 AERI AERIE PHARMACEUTICALS INC BFRTDG1 15.70 9,333 146,528.10
0.23 CASH 1.00 145,835 145,684.68
0.22 ATEC ALPHATEC HOLDINGS INC BD60BG7 14.10 10,185 143,608.50
0.22 TCMD TACTILE SYSTEMS BZB1XF2 42.17 3,388 142,871.96
0.22 PHM SM PHARMA MAR SA BMW2GT8 94.24 1,506 141,931.73
0.21 ACAD ACADIA PHARMACEU 2713317 15.90 8,551 135,960.90
0.21 NHI NATL HEALTH INVESTORS INC 2626125 57.40 2,345 134,603.00
0.21 LTC LTC PROPERTIES INC 2498788 33.23 4,023 133,684.29
0.20 DHC DIVERSIFIED HEAL BKRN595 3.41 36,698 125,140.18
0.19 HRTX HERON THERAPEUTICS INC BJ0XLZ3 11.66 10,233 119,316.78
0.19 PNTG PENNANT GROUP INC/THE BKTC976 29.61 4,000 118,440.00
0.18 2500 HK VENUS MEDTECH -H BL6V047 5.44 20,800 113,205.46
0.18 EPZM EPIZYME INC B9Z1QZ7 5.38 21,010 113,033.80
0.17 FGEN FIBROGEN INC BSDRYR8 11.70 9,396 109,933.20
0.17 BLUE BLUEBIRD BIO INC BBFL7S1 17.80 6,101 108,597.80
0.17 RDUS RADIUS HEALTH INC BM68KK1 12.12 8,915 108,049.80
0.17 GKOS GLAUKOS CORP BYMWL19 51.78 2,084 107,909.52
0.09 TBPH THERAVANCE BIOPHARMA INC BMNDK09 6.77 8,123 54,992.71
Holdings are subject to change.


Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.